NVSI-06-09 / Sinopharm 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NVSI-06-09 / Sinopharm
NCT05599516: Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Recruiting
3
16000
RoW
LIBP-Rec-Vaccine, BIBP-Rec-Vaccine, placebo
National Vaccine and Serum Institute, China, China National Biotec Group Company Limited, Lanzhou Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co Ltd.
COVID-19, Coronavirus Infections
10/23
12/23
NCT05293548: A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

Active, not recruiting
2
516
RoW
Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells)
National Vaccine and Serum Institute, China, China National Biotec Group Company Limited, Lanzhou Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co Ltd.
COVID-19
05/23
08/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
NVSI-06-09 / Sinopharm
NCT05599516: Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) Phase III Clinical Trial

Recruiting
3
16000
RoW
LIBP-Rec-Vaccine, BIBP-Rec-Vaccine, placebo
National Vaccine and Serum Institute, China, China National Biotec Group Company Limited, Lanzhou Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co Ltd.
COVID-19, Coronavirus Infections
10/23
12/23
NCT05293548: A Clinical Trial on Sequential Immunization of Recombinant COVID-19 Vaccine (CHO Cell, NVSI-06-09) and Inactivated COVID-19 Vaccine (Vero Cell)

Active, not recruiting
2
516
RoW
Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells)
National Vaccine and Serum Institute, China, China National Biotec Group Company Limited, Lanzhou Institute of Biological Products Co., Ltd, Beijing Institute of Biological Products Co Ltd.
COVID-19
05/23
08/23

Download Options